Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
Public ClinicalTrials.gov record NCT04932291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
"A Double-blind, Randomized, Placebo-controlled, Adaptive 14-week Phase IIb Trial to Evaluate the Efficacy and Safety of Vafidemstat in an Adult Borderline Personality Disorder (BPD) Population (PORTICO)"
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
PORTICO is a Phase IIb study to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population.
Study identification
- NCT ID
- NCT04932291
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 211 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 26, 2021 (Actual)
- Primary completion
- Oct 30, 2023 (Actual)
- Completion
- Nov 13, 2023 (Actual)
- Last update posted
- May 5, 2026
2021 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Excell Research Inc | Oceanside | California | 92056 | — |
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| New Life Medical Research Center | Hialeah | Florida | 33012 | — |
| Phoenix Medical Research LLC | Miami | Florida | 33165 | — |
| University of Chicago Institutional Review Board | Chicago | Illinois | 60637-1426 | — |
| Revive Research Institute | Elgin | Illinois | 60123 | — |
| Adams Clinical Trials, LLC | Watertown | Massachusetts | 02472 | — |
| Center for Emotioal Fitness | Cherry Hill | New Jersey | 08002 | — |
| Neurobehavioral Research Inc. | Cedarhurst | New York | 11516 | — |
| The Medical Research Network | New York | New York | 10128 | — |
| Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04932291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04932291 live on ClinicalTrials.gov.